Form D · Biotechnology
STRATATECH Corp
Madison, WI · CIK 0001161468
Offering snapshot reported Apr 6, 2010 · SEC filing
- Reported sold
- $3M Offering amount: $3M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 22, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 6, 2010 | Initial | $3,000,000 | No comparison | 2 | SEC filing |
| May 22, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Security to be acquired, Other
- Exemptions
- 06
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-58309
Debt instruments are convertible revolving promissory notes of up to $1,500,000 each.
Source: Form D, filed Apr 6, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| B. Lynn Allen Hoffmann, Ph D | Director, Executive |
| Robert T. Barnard | Executive |
| Joseph M. Davie, Md, Ph D | Director |
| F. Michael Hoffmann | Director |
| Tod B. Linstroth | Executive |
| Benjamin T. Montgomery, Md | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
505 S. Rosa Rd., Ste. 169
Madison, WI, 53719
Madison, WI, 53719